Enjosim: Funding, Investors & Team (Nov 2026)
Enjosim specializes in the R&D, manufacturing, and sales of self-delivery systems, particularly those for biomacromolecule pharmaceuticals.
Enjosim has raised $30.1M across 1 funding round on record, the most recent a Series B of $30.1M announced in Nov 2026.
That round is above the $15M median round size for China companies tracked on FundedIQ over the last two years.
Enjosim Company Profile and Key Stats
Latest funding round on record: Nov 2026.
Enjosim Funding Rounds
Enjosim Investors
12 investors are recorded in total; the 5 named above are those the record identifies.
Enjosim Funding in Context
Enjosim's latest round of $30.1M is above the median round in China. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Enjosim in Biopharma and Shanghai
Companies Similar to Enjosim
Afana Biotechnology is a company that provides research and development for mRNA technology, sequence…
Lingchuan Technology is a high-tech enterprise focusing on transcoding/AI chip research and development.
Boyi Biotechnology provides vital raw materials and complete solutions to biomedical customers in the in…
Guoquangzi is a manufacturer of quantum precision measurement devices.
Echiev is a developer of autonomous driving technology and application products includes intelligent and…
Tope is the pioneer and innovator in the field of new energy battery 3D printing technology.
Genrobot.ai develops AI-powered robots for automation, data analysis, and intelligent task management across…
Yitai Microelectronics is an automotive Ethernet chip developer company.
Jingshuo Technology focuses on the independent research and development of AI data closed loop and solutions
Juqiao Industry is a company that develops fiber sensor technologies.
NeuroXess develops brain-computer interface technologies and solutions for scientific research and medical…
Elite Robots is a robotics company that offers collaborative robots, composite robots, wheeled humanoid robots
Enjosim Funding FAQs
What does Enjosim do?
Enjosim specializes in the R&D, manufacturing, and sales of self-delivery systems, particularly those for biomacromolecule pharmaceuticals.
How much funding has Enjosim raised?
Enjosim has raised $30.1M across 1 round on record. The most recent is a Series B of $30.1M announced in Nov 2026.
When did Enjosim last raise funding?
Enjosim's most recent funding round on record is a Series B of $30.1M, announced in Nov 2026.
Who has invested in Enjosim?
Investors on record for Enjosim include Addor Capital, Qiming Venture Partners, Luminous Ventures (former Lightspeed China Partners), Co-Stone Venture Capital, CICC Capital. FundedIQ records 12 investors in total.
Where is Enjosim headquartered?
Enjosim is based in Shanghai, China.
How many employees does Enjosim have?
Enjosim is in the 51-100 employee band.
When was Enjosim founded?
Enjosim was founded in 2021.
About FundedIQ's Enjosim Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Enjosim is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.